This is a proposal to 1) study the regulation of arachidonoyl-CoA synthesis in mammalian cells, and 2) attempt to identify the pool of arachidonoyl-CoA which is esterified into phospholipid and then released for production of icosanoids. We have recently demonstrated that icosanoid production in cultured cells can be controlled at a step prior to arachidonate release from phospholipid, namely, at the point of arachidonoyl-CoA formation. This represents a newly discovered option for the control of icosanoid formation. Icosanoids are implicated in a multitude of disease processes including atherosclerosis and thrombosis leading to myocardial infarction and stroke and autoimmune disease, produced by uncontrolled inflammation. We have recently shown, using the prostaglandin E2 producing cell line HSDM1C1 and several cell lines unique in various aspects of icosanoid precursor fatty acid metabolism, that arachidonoyl-CoA formation in mammalian cells involves three metabolic pathways: 1) the Delta6 desaturase/elongase/ Delta5 desaturase pathway, 2) the non-specific long chain acyl-CoA synthetase, and 3) arachidonoyl-CoA synthetase. Furthermore, we have been able to alter the flux through these pathways. Using our cultured cell lines, we propose to study the regulation of each of the three pathways leading to arachidonoyl-CoA formation. Specifically, we plan to study: 1) the induction of Delta6 desaturase and control of induction by fatty acid, 2) the identification of a factor(s) in an extract of horse serum which we have shown controls arachidonoyl-CoA synthetase activity, and 3) the induction of non-specific acyl-CoA synthetase activity by micromolar concentrations of various fatty acids. We will also investigate the capacity of arachidonate derived from its precursor fatty acids to enter the pool of arachidonoyl-CoA destined for prostaglandin E2 synthesis. The information from our studies on arachidonoyl-CoA synthesis, a new control point for icosanoid formation, could ultimately have a significant impact on icosanoid-mediated disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK037454-01
Application #
3236371
Study Section
Biochemistry Study Section (BIO)
Project Start
1986-08-01
Project End
1990-07-31
Budget Start
1986-08-01
Budget End
1987-07-31
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Muszbek, L; Haramura, G; Cluette-Brown, J E et al. (1999) The pool of fatty acids covalently bound to platelet proteins by thioester linkages can be altered by exogenously supplied fatty acids. Lipids 34 Suppl:S331-7
Kabakibi, A; Morse, C R; Laposata, M (1998) Fatty acid ethyl esters and HepG2 cells: intracellular synthesis and release from the cells. J Lipid Res 39:1568-82
Kabakibi, A; Vamvakas, E C; Cannistraro, P A et al. (1998) Collagen-induced whole blood platelet aggregation in patients undergoing surgical procedures associated with minimal to moderate blood loss. Am J Clin Pathol 109:392-8
Bird, D A; Kabakibi, A; Laposata, M (1997) The distribution of fatty acid ethyl esters among lipoproteins and albumin in human serum. Alcohol Clin Exp Res 21:602-5
Saghir, M; Werner, J; Laposata, M (1997) Rapid in vivo hydrolysis of fatty acid ethyl esters, toxic nonoxidative ethanol metabolites. Am J Physiol 273:G184-90
Gorski, N P; Nouraldin, H; Dube, D M et al. (1996) Reduced fatty acid ethyl ester synthase activity in the white blood cells of alcoholics. Alcohol Clin Exp Res 20:268-74
Bird, D A; Laposata, M; Hamilton, J A (1996) Binding of ethyl oleate to low density lipoprotein, phospholipid vesicles, and albumin: a 13C NMR study. J Lipid Res 37:1449-58
Laposata, M; Szczepiorkowski, Z M; Brown, J E (1995) Fatty acid ethyl esters: non-oxidative metabolites of ethanol. Prostaglandins Leukot Essent Fatty Acids 52:87-91
Teruya, J; Cluette-Brown, J; Szczepiorkowski, Z M et al. (1995) Mode of transport of fatty acid to endothelial cells influences intracellular fatty acid metabolism. J Lipid Res 36:266-76
Bird, D A; Szczepiorkowski, Z M; Trace, V C et al. (1995) Low-density lipoprotein reconstituted with fatty acid ethyl esters as a physiological vehicle for ethyl ester delivery to intact cells. Alcohol Clin Exp Res 19:1265-70

Showing the most recent 10 out of 25 publications